Case report: Olverembatinib monotherapy: the chemotherapy-free regimen for an elderly patient with relapsed Ph-positive acute lymphoblastic leukemia

Background: The advent of first- and second-generation BCR/ABL1 tyrosine kinase inhibitors (TKIs), such as imatinib and dasatinib, has markedly improved the clinical outcomes of patients with philadelphia chromosome–positive acute lymphoblastic leukemia (Ph(+)-ALL). However, due to acquired drug res...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jianghua, Li, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687180/
https://www.ncbi.nlm.nih.gov/pubmed/38035030
http://dx.doi.org/10.3389/fphar.2023.1320641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687180/
https://www.ncbi.nlm.nih.gov/pubmed/38035030
http://dx.doi.org/10.3389/fphar.2023.1320641

Ejemplares similares